MEMOL:专家组合通过多头注意力进行多式学习,以预测药物毒性
Jae-Woo Chu1, Jong-Hoon Park1, Young-Rae Cho2
1Department of Software, Yonsei University Mirae Campus, Yeonsedae-gil 1, Wonju-si, 26493, Gangwon-do, Republic of Korea.
Computer methods and programs in biomedicine
|October 5, 2025
概括
我们开发了MEMOL,这是一种用于药物毒性预测的新型深度学习框架. MEMOL有效地集成了分子图像,图形和指纹,大大提高了对现有方法的预测准确性.
科学领域:
- 计算化学是一种计算化学.
- 化学信息学 化学信息学
- 发现药物的发现.
背景情况:
- 准确的药物毒性预测对于有效的药物开发至关重要.
- 深度学习为复杂的分子毒性预测提供了有希望的解决方案.
- 综合多种分子数据的多模式方法正在出现,但需要更好的融合策略.
研究的目的:
- 为精确的药物毒性预测开发一个有效的多式联络深度学习框架.
- 探索各种分子表征融合的新方法.
- 增强特征提取和模式集成,以提高预测性能.
主要方法:
- 拟议的MEMOL (多模式学习专家组合) 使用多头注意力.
- 集成的分子图像,图形和指纹模式.
- 在注意力机制中使用了稀疏的专家混合.
- 利用自我和交叉注意力来增强功能和融合.
主要成果:
- 在毒性基准数据集上,MEMOL的性能超过了最先进的方法.
- 实现了高达8.33%的AUROC和9.11%的AUPRC.
- 通过使用所有三种模式,表现出一致的性能改进.
- 废弃性研究证实了多式联运一体化专家稀疏混合的有效性.
结论:
- MEMOL提供了一个强大的框架,用于整合多样化的分子表示,用于毒性预测.
- 该模型在各种数据集中显示出优越和一致的性能.
- 这种方法提高了药物开发中毒性预测的准确性和效率.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Multicompartment Models: Overview
498
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
498
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Therapeutic Drug Monitoring: Drug Analysis Methods
177
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
177
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Therapeutic Drug Monitoring: Overview and Classification
307
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
307


